The Index
400 dossiers · 1 need attention
A research screener for every company we cover. Search a name or ticker, then sort and triage dossiers by coverage freshness, our conviction and trading relevance.
| ALB is a high-quality, low-cost lithium asset wearing the price tag of a leveraged call option on the lithium spot price — own the resources, not the P&L; the stock is the commodity in a cyclical costume. | — | 0 | |
| The world's lowest-cost EV/battery manufacturer is now margin-bleeding in a brutal domestic price war it helped start; the entire bull case has migrated to a high-margin export ramp that tariffs and a Brazil/Hungary regulatory cloud are built to throttle — cheap on forward P/E only if you trust earnings that GMT says are flattered by ~¥300B of supply-chain-financed hidden debt. | — | 0 | |
| The cheapest dominant company in the world — a 40%-share, 27%-ROE compounder priced at ~22x because it carries a Chinese-passport discount and a US-blacklist overhang the market refuses to underwrite away; bullish, but the re-rate needs a geopolitical thaw that may never come. | — | 0 | |
| A great battery operator strapped to a collapsing demand curve and a U.S. subsidy that is its only profit — the franchise is real, but the 2027-2032 order book just lost ~$9B of contracted Ford/FBPS volume and AMPC repeal is an existential tail risk; WATCHING, not buying, until the ESS pivot proves it can replace lost auto cells at a real margin. | — | 8 | |
| A premium-cell incumbent being squeezed from below by Chinese LFP scale and above by its own Tesla over-concentration — but the unit now has a genuine second engine (data-center backup, ~80% share) that the parent's 46x-PER stock does not yet price as a battery turnaround. | — | 8 | |
| A loss-making #9 EV-cell laggard re-rating on an ESS/data-center pivot the market is pricing as a turnaround — the call is whether US grid-storage demand and 2027 solid-state outrun Chinese LFP deflation before the balance sheet (rights issue + Display-stake sale) runs out of runway. | — | 8 |